Ignite Creation Date:
2024-05-06 @ 8:57 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02860286
Status:
COMPLETED
Last Update Posted:
2021-04-09
First Post:
2016-07-27
Brief Title:
Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma
Sponsor:
Epizyme Inc
Organization:
Epizyme Inc
Organization Data
Organization:
Epizyme Inc
Class:
INDUSTRY
Study ID:
EZH-203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Epizyme Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None